Re: Questions

I will get more detailed answers but for now 1. not sure what you mean by R &d ? . no input from the foundation into investments.. donors can choose from either a custom made portfolio.. or a a choice of silos, and be able to switch . ( mutual fund concept) 2. mostly initally american. initially , however we should be ready with an offshore arm. - especailly for vaccines. 3. The donor advised limits influence re grants. but allows great fliexibility on investments.. anonymoity is varied , according to both gifts to and gifts from 4. pooled is not really necessary but would be availble for those that preferred it. 5. billions of dollars. the first two years. tens of billions by year 4. timelimne depends only on jpm ability to organizze, legal, structure internet presence, staffing. etc 5. exists in perpetuity, with succession controls. 6. there will be acess to the current foundations pools of targets. but would be looking for both new opportunities with metrics for success.

Here are some questions we have in advance of the meeting, to the extent we can find the answers:

What role will the Gates foundation play vis-a-vis other donors with respect to marketing, sharing of R&D, grant making and investments?

What is the profile of the potential donors, including residence & tax status? What level of influence will they want to maintain across investments and grant making? How important is anonymity?

Is pooling of investments and pooled grant making a core feature of the offering?

What is the potential funding amount and what is the anticipated funding rate?

What is the timeline for launch? Is the objective to create a vehicle to exist in perpetuity or is it a thematic spend-down over time?

Are there specific themes and charities identified for grant making or is there a broad scope of charitable targets?

These are all generic questions from the team, but to the extent we can get any guidance on some of the direction, it would be very helpful before the 31st.

EFTA00917611

From Maroon Bells,

Mary

The answer to the R&D question is how do we access the work they have done on the causes they are passionate about like education and healthcare.

Many people view them as subject matter experts and we are wondering if they would be willing to share that as part of the offering

ME